Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
4.690
+0.110 (2.40%)
Aug 30, 2024, 4:00 PM EDT - Market closed

Mereo BioPharma Group Revenue

Mereo BioPharma Group had revenue of $1.00M in the twelve months ending June 30, 2024, down -88.89% year-over-year. In the year 2023, Mereo BioPharma Group had annual revenue of $10.00M.

Revenue (ttm)
$1.00M
Revenue Growth
-88.89%
P/S Ratio
n/a
Revenue / Employee
$30,303
Employees
33
Market Cap
720.41M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202310.00M--
Dec 31, 2022---
Dec 31, 202136.46M--
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Community Health Systems 12.55B
Pacira BioSciences 690.31M
Travere Therapeutics 177.64M
Wave Life Sciences 110.50M
CureVac 70.57M
Simulations Plus 66.98M
Exscientia 26.57M
Applied Therapeutics -333.00K
Revenue Rankings